Cellnex, ES0105066007

Cellnex stock: Barclays sets EUR 38.00 target for Cellnex stock

Published on 10/19/2026 at 16:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
First-half revenue was EUR 1.99 billion, up 5.00 percent. Cellnex stock costs EUR 25.46 on October 19, 2026, down 0.62 percent versus Xetra close.

Barclays target guides valuation

  • Barclays set a EUR 38.00 target for Cellnex on October 15, 2026, 49.26 percent above the price.
  • First-half 2026 revenue reached EUR 1.99 billion, up 5.00 percent.
  • Cellnex stock costs EUR 25.46 at Lang & Schwarz on October 19, 2026 at 4:06 p.m. CEST, down 0.62 percent versus the Xetra close of October 16, 2026, and 22.16 percent below the 52-week high.
  • Cellnex listed November 5, 2026, for its next quarterly results.
Pop-Art-Comic mit Sendemast und Stadtsilhouette visualisiert plakativ Cellnex Telecom S.A., ISIN ES0105066007, Illustration mit AI erstellt.

Cellnex (ISIN ES0105066007) received a EUR 38.00 price target from Barclays on October 15, 2026, putting the target 49.26 percent above the EUR 25.46 price. Markets Insider reported that Barclays analyst Maurice Patrick maintained a Buy rating and set the target at EUR 38.00 on October 15, 2026. At Lang & Schwarz, Cellnex stock was trading at EUR 25.46 on October 19, 2026 at 4:06 p.m. CEST, down 0.62 percent versus the Xetra close of October 16, 2026 at EUR 25.62.

First-half revenue rises 5.00 percent

Cellnex's operating picture provides a second anchor for the valuation discussion. The company reported first-half 2026 revenue of EUR 1.99 billion, up 5.00 percent from the comparable period. Cellnex also reported free cash flow of EUR 301.0 million for the same period and announced EUR 200.0 million of additional shareholder remuneration in 2026, according to the company's investor-relations page dated July 30, 2026. Cellnex published the figures.

Stock stays below the yearly high

The current price sits EUR 7.25 below Cellnex's 52-week high of EUR 32.71 and EUR 3.62 above its 52-week low of EUR 21.84, both as of October 19, 2026. That places the stock 22.16 percent below the high and 16.59 percent above the low. The Lang & Schwarz bid was EUR 25.44 and the ask EUR 25.48 at 4:06 p.m. CEST. Trading volume stood at 379,683 shares against an average of 1,385,076 shares.

Valuation and the next results date

Cellnex had a market capitalization of EUR 16.8 billion, a negative price-to-earnings ratio of 49.43 and a dividend yield of 3.00 percent as of October 19, 2026. The company's next quarterly results are scheduled for November 5, 2026, according to the investor-relations calendar. The date gives investors a defined point for testing whether the first-half revenue trend is continuing.

Comparison with peers

Cellnex (BME, EUR): minus 0.62 percent, P/E minus 49.43, market capitalization EUR 16.8 billion

American Tower (NYSE, USD): minus 1.07 percent, P/E 25.27, market capitalization USD 85.4 billion

SBA Communications (NASDAQ, USD): minus 1.84 percent, P/E 19.77, market capitalization USD 19.5 billion

Price and investor frame

Cellnex's euro price remains materially below the 52-week high while the Barclays target stands above the current quotation. The next results date and the first-half cash-flow figures give the market two dated reference points for the valuation.

The further course of trading is shown by the continuously updated real-time quote of Cellnex stock.

Cellnex stock market data

  • Company: Cellnex Telecom, S.A.
  • ISIN: ES0105066007
  • Ticker: CLNX
  • Primary exchange: BME
  • Price Lang & Schwarz (as of October 19, 2026, 4:06 p.m. CEST): EUR 25.46
  • Change versus Xetra close: minus 0.62 percent
  • Xetra close (October 16, 2026): EUR 25.62
  • Market capitalization: EUR 16.8 billion (as of October 19, 2026)
  • 52-week range: EUR 21.84-EUR 32.71 (as of October 19, 2026)
  • Sector / Industry: Communication Services / Telecommunications Services
  • Index membership: IBEX 35
  • Next earnings date: November 5, 2026

Market context: Market report IBEX 35.

More news and analyses on Cellnex stock

Disclaimer...
en | ES0105066007 | CELLNEX | boerse | 70363648 | bgmi